Fresenius Group Overview

• The Health Care Group
  • Group Overview
  • Fresenius Medical Care
  • Fresenius Kabi
  • Fresenius Helios
  • Fresenius Vamed
  • Management
    • Management Board
    • Supervisory Board
    • Corporate Governance
    • Compliance
  • Fields of Work
    • Dialysis
    • Apheresis
    • Infusion Therapy
    • Clinical Nutrition
    • Transfusion Technology
    • Hospitals
    • Health Prevention
    • Health Tourism
  • Worldwide
  • Sustainability
    • Our Responsibility
    • Sustainable Development Goals
    • Our material Sustainability Topics
  • History
  • Else Kröner-Fresenius Foundation
  • Calendar
  • Contacts
  • World’s largest provider of dialysis products and services
  • Products for chronically and critically ill patients
  • Europe's leading private hospital operator
  • Projects and services for health care facilities
• Stories
  • Doubling up on a second chance
  • A robot at the operating table
  • Midwife, a dream job
  • My 50 years of dialysis
  • In battle against the coronavirus
  • An almost irreplaceable organ
  • Living life to the fullest with dialysis
  • Growing up with parenteral nutrition
  • The History of Dialysis
  • Serving patients in Swaziland
  • "I want to help others, so they won’t give up"
  • From a local pharmacy to a global corporation

  Archive „Stories“

• Investors
  • Highlights
  • Capital Markets Day
  • Share
    • Key Data
    • Share Price
    • Dividends
    • Total Return Calculator
    • Analysts & Consensus
    • Shareholder Structure
    • Capitalization
    • ADR
  • Investor News
  • Strategy & Outlook
    • Goals and Strategy
    • Financial Performance Indicators
    • Group Structure
    • Outlook
  • Events & Roadshows
  • Financial Reports & Presentations
  • Financial Results
  • Ad-hoc News
  • Group Figures
    • Alternative Performance Measures
    • Interactive Tool
  • Annual General Meeting
    • Dr. Gerd Krick and an era of success at Fresenius
  • Credit Relations
    • Financing Strategy & Targets
    • Financing Mix
    • Maturities
    • Bonds & Convertible Bonds
      • Bonds 2020 - 2027
      • Bonds 2020 – 2026
      • Bonds 2020 – 2033
      • Bonds 2021 – 2025
      • Bonds 2021 – 2028
      • Bonds 2021 – 2031
    • Commercial Paper Program
    • Rating
    • Key Credit Data
  • FAQ
  • Contacts

  Contact

  Fresenius SE & Co. KGaA

  Investor Relations & Sustainability

  +49 (0) 6172 608-2485
  ir-fre@fresenius.com

• Media
  • News
  • Social Media
  • Calendar
  • Contacts
  • Media Center

  Contact

  Matthias Link

  Senior Vice President Corporate Communications

  T: +49 (0) 6172 608-2872
  matthias.link@fresenius.com

• Careers
• Menu
• Filter results

  • Chapter

    • The Health Care Group (0)
    • Stories (0)
    • Investors (0)
    • Media (0)

  • Format

    • Website (0)
    • PDF (0)

• Share

  • Facebook
  • Twitter
  • LinkedIn
  • Xing
  • E-Mail

  Services

  • Deutsch
  • Print
  • Contact
  • RSS